INVA
INVA
NASDAQ · Pharmaceuticals

Innoviva Inc

$24.08
+0.53 (+2.25%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 1 9%
Sell 1 9%
Price Target
Analyst Price Target +62.6% upside
Low Target $23.99
Average Target $39.16
High Target $41.33
Current Price $24.08
Current
$24.08
Target
$39.16
$23.99 $39.16 avg $41.33
Scenario Analysis
Bear Case
$23.99
-0.4%
Low target
Base Case
$39.16
+62.6%
Avg target
Bull Case
$41.33
+71.6%
High target
Risk/Reward
191.7x
Highly favorable
Price in Context
52-Week High
$25.15
-4.3% from high
52-Week Low
$16.52
+45.8% from low
Target vs 52W High
$39.16
+55.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%